| ID: 129994382 | ATAC-STARR-seq lymphoblastoid silent region 16243 [Homo sapiens (human)] | Chromosome 5, NC_000005.10 (113513950..113514179) | | |
| ID: 129994381 | ATAC-STARR-seq lymphoblastoid active region 22921 [Homo sapiens (human)] | Chromosome 5, NC_000005.10 (113513450..113513499) | | |
| ID: 129661493 | ReSE screen-validated silencer GRCh37_chr5:113001311-113001413 [Homo sapiens (human)] | Chromosome 5, NC_000005.10 (113665614..113665716) | | |
| ID: 129389347 | MPRA-validated peak5423 silencer [Homo sapiens (human)] | Chromosome 5, NC_000005.10 (113520489..113520689) | | |
| ID: 127403555 | OCT4-NANOG hESC enhancer GRCh37_chr5:113111806-113112399 [Homo sapiens (human)] | Chromosome 5, NC_000005.10 (113776109..113776702) | | |
| ID: 127403554 | NANOG hESC enhancer GRCh37_chr5:113018255-113018802 [Homo sapiens (human)] | Chromosome 5, NC_000005.10 (113682558..113683105) | | |
| ID: 127403553 | H3K27ac hESC enhancer GRCh37_chr5:112849193-112849694 [Homo sapiens (human)] | Chromosome 5, NC_000005.10 (113513496..113513997) | | |
| ID: 126807480 | MED14-independent group 3 enhancer GRCh37_chr5:113010540-113011739 [Homo sapiens (human)] | Chromosome 5, NC_000005.10 (113674843..113676042) | | |
| ID: 124901046 | uncharacterized LOC124901046 [Homo sapiens (human)] | Chromosome 5, NC_000005.10 (113511859..113513658, complement) | | |
| ID: 107986441 | uncharacterized LOC107986441 [Homo sapiens (human)] | Chromosome 5, NC_000005.10 (113633306..113695327) | | |
| ID: 106479543 | RNA, U4atac small nuclear 13, pseudogene [Homo sapiens (human)] | Chromosome 5, NC_000005.10 (113493835..113493960) | | |
| ID: 105379127 | uncharacterized LOC105379127 [Homo sapiens (human)] | Chromosome 5, NC_000005.10 (113739472..113777308, complement) | | |
| ID: 64848 | YTH N6-methyladenosine RNA binding protein C2 [Homo sapiens (human)] | Chromosome 5, NC_000005.10 (113513694..113595284) | CAHL, hYTHDC2 | 616530 |